| 08:00 – 09:15 am | S 12: Free papers III Chairmen: B. Lehner, U. Gerlach |
|
|---|---|---|
| S 12.1 | Two-stage Reimplantation with Applicationspacer for Antibiotics in Septic Total Arthroplasty H. Thabe (Bad Kreuznach, Germany) |
6’ |
| S 12.2 | Analysis of the 18 (7%) Failed Cases in 282 One Stage Exchanges for Periprosthetic Infection of the Hip- and Kneejoint J. Wodtke (Hamburg, Germany) |
6’ |
| S 12.3 | Interdisciplinary two stage revision procedere for prosthetic joint infection S. Gravius, M. D. Wimmer, T. Hoppe, S. Petersdorf, N. Kraska, G. Pagenstert (Bonn, Germany) |
6’ |
| S 12.4 | Risk factors for failed infectious salvage in cases of chronic prosthetic hip infections U. Spiegl, R. Pätzold, J. Friederichs, M. Militz, V. Bühren (Murnau, Germany) |
6’ |
| S 12.5 | Success of two-stage hip revision for infection in patients treated with previous irrigation and debridement. B. Zmistowski, A. Carter, J. Parvizi, S. Nannapaneni, M. S. Austin, J. J. Purtill (Philadelphia, USA) |
6’ |
| S 12.6 | Successs of Repeat Two-Stage Revision for Periprosthetic Joint Infection of the Hip J. Mortazavi, J. T. O’Neil, B. Zmistowski, M. S. Austin, J. J. Purtill, J. Parvizi (Philadelphia, USA) |
6’ |
| S 12.7 | Short Term Results of a New Modular Spacer Arthrodesis in Large Bone Defects after Failed Knee Arthroplasty R. Wetzel, L. Rabenseifner (Baden-Baden, Germany) |
6’ |
| S 12.8 | Two-Stage Revision Arthroplasty Due To Reinfection After Septic Hip Revision Arthroplasty – A Retrospective Analysis A. Abdulazim, C. Kappler, M. Kemmerer, G. Walter, R. Hoffmann (Frankfurt/Main, Germany) |
6’ |
| Total discussion | 15’ | |
| 09:15 – 10:35 am | S 13: Biomet Award Session All presenters in this session get the chance to win one of the Biomet Innovation Awards. |
|
| S 13.1 | Antibacterial efficacy of new gentamicin-releasing coatings for cementless prostheses D. Neut, R. Dijkstra, J. Thompson, H. van der Mei, H. Busscher (Groningen, Netherlands) |
6’ |
| S 13.2 | Bacterial resistance development in infected total hip arthroplasties in Norway O. Lutro, H. Langvatn, L. B. Engesæter, J. C. Schrama, G. Hallan, H. Dale, B. Espehaug, H. Sjursen (Bergen, Norway) |
6’ |
| S 13.3 | Incidence and risk factors of in-hospital surgical site infection after primary total hip and knee arthroplasty L. Poultsides, Y. Ma, A. Gonzalez Della Valle, Y.-L. Chiu, L.Gaber-Baylis, M. Mazumdar, T. P. Sculco, S. G. Memtsoudis, (New York, USA) |
6’ |
| S 13.4 | Results of 688 revisions for infected THA in the Norwegian Arthroplasty Register L. B. Engesæter, H. Dale, J. Schrama, O. Lutro, H. Langvatn, A. L. Stein, H. Geir (Bergen, Norway) |
6’ |
| S 13.5 | Early diagnosis of infection by detection of microbial heat production in sonication fluid of removed implants – a pilot study J. Steinrücken, M. Clauss, A. Bizzini, U. Furustrand, A. Trampuz, O. Borens (Lausanne, Switzerland) |
6’ |
| S 13.6 | In vitro activity of a biofilm disaggregating substance against biofilm formed by Staphylococcus aureus and Pseudomonas aeruginosa on polythene and titanium discs E. De Vecchi, C. L. Romanò, G. Palma, L. Rovetto, L. Drago (Milano, Italy) |
6’ |
| S 13.7 | Molecular markers for diagnosis of periprosthetic joint infection C. Jacovides, J. Parvizi, B. Adeli, K. am Jung (Philadelphia, USA) |
6’ |
| S 13.8 | Neutrophil-derived circulating free DNA (cf-DNA/NETs) – A new diagnostic parameter for septic arthritis T. Lögters, A. Paunel-Görgülü, R. Krauspe, M. Jäger, S. Flohé, J. Windolf (Düsseldorf, Germany) |
6’ |
| S 13.9 | Association of TLR2-R753Q polymorphism with chronic osteomyelitis A. Tsezou, F. Kostopoulou, L. Poultsides, K. N. Malizos (Larissa, Greece) |
6’ |
| S 13.10 | Treatment of extensive osteitis with antibiotic impregnated human bone graft versus antibiotic cement in a one stage revision procedure in an animal model K.-H. Kaudela, U. Burner, C. Bonfert, R. Hruby, H. Winkler (Wels, Austria) |
6’ |
| Total discussion | 20’ | |
| 10:35 – 11:05 am | Break and exhibition | |
| 11:05 am - 01:00 pm | S 14: Infected endoprostheses II Chairmen: L. Frommelt, R. Ascherl |
|
| S 14.1 | 10 reasons for second stage revision C. Romano (Milano, Italy) |
15’ |
| S 14.2 | 1 reason for single stage revision or more H. Winkler (Wien, Austria) |
15’ |
| S 14.3 | Advantages with PCR of Biofilm in diagnostics of prosthetic infection. |
6’ |
| S 14.4 | Two-Stage Exchange Arthroplasty for Infected Total Hip Arthroplasty: Are the Results as Good as They Seem? A. Carter, W. Arnold, E. Davis, K. Azzam, J. Parvizi (Philadelphia, USA) |
6’ |
| S 14.5 | Characteristics and outcome of knee prosthetic joint infections: A 10-year cohort study M. Vauthey, R. Baalbaki, A. Trampuz, O. Borens (Lausanne, Switzerland) |
6’ |
| S 14.6 | Efficacy of Irrigation and Debridement for Acute Post-Operative, Acute Hematogenous and Chronic Periprosthetic Joint Infection L. Koyonos, B. Zmistowski, C. J. Fedorka, J. J. Purtill, P. F. Sharkey, J. Parvizi (Philadelphia, USA) |
6’ |
| S 14.7 | Predictors of Successful Reimplantation of Two-Stage Revision of Total Knee Arthroplasty for Periprosthetic Infection D. Vegari, A. Ho, B. Zmistowski, W. J. Hozack, M. S. Austin, J. Parvizi (Philadelphia, USA) |
6’ |
| S 14.8 | Results of treatment of deep infection of 25 total knee prostheses by debridement and local antibiotics with prosthesis in situ. J. Geurts, D. Janssen, G. Walenkamp (Maastricht, Netherlands) |
6’ |
| S 14.9 | Comparison of various methods for femoral fixation of custom-made hip spacers K. Anagnostakos, J. Jung, E. Schmitt, J. Kelm, N. Schmid (Homburg/Saar, Germany) |
6’ |
| S 14.10 | Two-stage total hip arthroplasty for infection: Instability is a major problem B. Moore, J. Mortazavi, C. Restrepo, J. Parvizi, W. J. Hozack, P. F. Sharkey (Philadelphia, USA) |
6’ |
| S 14.11 | Preformed spacer and uncemented prosthesis for two-stage treatment of septic hip arthritis: a valuable option. C. L. Romanò, E. Meani, D. Romanò, N. Logoluso, A. Elia (Milano, Italy) |
6’ |
| S 14.12 | Gait of patients with preformed, articulated, knee spacers is similar to that of normal subjects walking at low-speed N. Logoluso, G. Melegati, C. Champlon, C. Romanò (Milano, Italy) |
6’ |
| S 14.13 | Diagnosis of Periprosthetic Joint Infection: The Role of a Simple, yet Unrecognized, Enzyme J. Parvizi, K. Azzam, C. Jacovides, V. Antoci, E. Ghanem (Philadelphia, USA) |
6’ |
| Total discussion | 20’ | |
| 01:00 - 01:30 pm | S 15: Outlook EBJIS Chairmen: V. Heppert |
|
| S 15.1 | EBJIS – Study group on implant infections A. Trampuz, C. Wagner (Ludwigshafen, Germany) |
15’ |
| S 15.2 | The danish approach to conquer bacterial biofilm K. Kirketerp-Möller (Kopenhagen, Denmark) |
15’ |
| 01:30 - 02:00 pm | Closing ceremony Biomet Awards The award titles are:
|
|
| 02:00 pm | Farewell soup | |

29th Annual Meeting
of the European Bone and Joint Infection Society
Stadthalle Heidelberg, Germany
September 2 – 4 | 2010